Tue, Sep 16, 2014, 3:54 PM EDT - U.S. Markets close in 6 mins.

Recent

% | $
Quotes you view appear here for quick access.

OncoGenex Pharmaceuticals, Inc. Message Board

  • heman_s heman_s Dec 4, 2011 1:44 PM Flag

    Question for drKuvaz pazzingaz

    As you guyz are the veteran, I would like your input. Answers from other posters are also welcome as long as they are not derogatory. Last time when OGXI presented phase 2 data in May 2009 at ASCO annual conference, the SP shot from around 6 to 35. OGX-427 is to be presented Asco GU 2012 for prostate cancer.I know its not a big conference as ASCO annual conf, but do you guyz expect to see any meaningful data n corresponding bump in SP?
    Also the trial is evaluating disease free survival at 12 weeks, will they present the OS data also ? The 10 Q filing only says interim data to be presented at Asco GU 2012 but it doesn't say what parameters will be presented.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
OGXI
2.93-0.14(-4.56%)3:54 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.